Men's Health
Men's health guidance, trial intelligence and education across prostate disease, cardiometabolic risk and long-term condition management.
Latest Guidelines
Testicular Cancer: Diagnosis and Management (NICE NG303)
Refer men with testicular lump or swelling urgently to urology within 2 weeks without delaying for primary care ultrasound; perform scrotal ultrasound as first-line imaging and…
Erectile Dysfunction: Assessment and Management (NICE CG1097)
Take a sexual history exploring onset, severity, partner concerns and quality of life impact; simultaneously assess cardiovascular risk and screen for diabetes, hypertension, hyperlipidaemia, and testosterone…
Testosterone Deficiency in Men: Investigation and Management (BSSM Guidelines)
Measure serum testosterone between 08:00–11:00 on two separate occasions (repeat if initial result 9–12 nmol/L); confirm deficiency only when total testosterone
Lower Urinary Tract Symptoms in Men: Assessment and Management (NICE CG97)
Obtain focused history and perform urinalysis (dipstick) to exclude urinary tract infection before further investigation in all men presenting with lower urinary tract symptoms. Use the…
Prostate Cancer: Diagnosis and Management (NICE NG131)
Offer PSA testing with risk calculators (such as ERSPC) to men aged 50–69 years on request, and to men aged 40–49 years with African or Caribbean…
Trial Radar
Dose dE-eScalaTion IN prostATe radIOtherapy usiNg an MR-Linac in 2 Fractions
Dose dE-eScalaTion IN prostATe radIOtherapy usiNg an MR-Linac in 2 Fractions is Recruiting • Phase not applicable •…
PHASE3A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer. is Recruiting •…
PHASE1Substudy 01A: Safety and Efficacy of Opevesostat (MK-5684)-Based Treatment Combinations or Opevesostat Alone in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-01A)
Substudy 01A: Safety and Efficacy of Opevesostat (MK-5684)-Based Treatment Combinations or Opevesostat Alone in Participants With Metastatic Castration-resistant…
PHASE3A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post…
Clinical News
The truth about taking testosterone
Testosterone Use: Key Clinical Takeaways Testosterone replacement therapy should be individualised based on symptom assessment and biochemical confirmation…
03 Dec 2025Prostate cancer screening: What you need to know
Everything you need to know about the decision on who should be screened for prostate cancer. This update…
Relevant Mechanisms
PARP Inhibition — DNA Damage Response
PARP Inhibition — DNA Damage Response is a clinically relevant Drug Science explainer. Poly(ADP-ribose) polymerase (PARP) enzymes, principally PARP1 and…
MechanismPD-1/PD-L1 Immune Checkpoint
PD-1/PD-L1 Immune Checkpoint is a clinically relevant Drug Science explainer. The programmed cell death protein-1 (PD-1) pathway is a critical…
CPD, Podcasts & Webinars
No specialty-tagged education live yet
Men's Health podcasts, webinars and CPD modules will appear here as new education is published and tagged.
Useful starting points in Men's Health
The truth about taking testosterone
Testosterone Use: Key Clinical Takeaways Testosterone replacement therapy should be individualised based on symptom assessment and biochemical confirmation…
MechanismPARP Inhibition — DNA Damage Response
PARP Inhibition — DNA Damage Response is a clinically relevant Drug Science explainer. Poly(ADP-ribose) polymerase (PARP) enzymes, principally…
MechanismPD-1/PD-L1 Immune Checkpoint
PD-1/PD-L1 Immune Checkpoint is a clinically relevant Drug Science explainer. The programmed cell death protein-1 (PD-1) pathway is…
Education that still supports this area
SGLT2 Inhibitors: From Glycaemia to Heart Failure and Chronic Kidney Disease
recorded webinar focused on SGLT2 Inhibitors in diabetes and metabolic medicine. Use the recording with the slide outline…
WebinarJAK Inhibitors: Updated Safety Signals, Patient Selection and Post-ORAL Surveillance
Recorded webinar focused on JAK inhibitors in rheumatology and immune-mediated inflammatory disease. Reviews JAK-STAT signalling, patient selection, ORAL…
WebinarGLP-1 Agonists: Semaglutide, Tirzepatide and the Cardiovascular Revolution
recorded webinar focused on GLP-1 Agonists in diabetes and metabolic medicine. Use the recording with the slide outline…
Follow Men's Health safety updates
Get MHRA safety alerts and clinically relevant updates for this specialty in your ClinicaliQ digest.
Follow Men's Health
Choose guideline, trial, Drug Science and education updates for this specialty.